IMPLANTABLE COLLAMER LENS (ICL)
Report
- Report Number
- 2023826-2020-02833
- Event Type
- Injury
- Date Received
- December 1, 2020
- Date of Event
- September 19, 2020
- Report Date
- November 5, 2020
- Manufacturer
- STAAR SURGICAL COMPANY
- Product Code
- QCB
- PMA / PMN Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
ADDITIONAL INFORMATION: B5- THE REPORTER INDICATED THE SURGEON IMPLANTED A 13.2MM VTICMO13.2 IMPLANTABLE COLLAMER LENS, -10.0/+2.0/089 (SPHERE/CYLINDER/AXIS) INTO THE PATIENT'S RIGHT EYE (OD) ON (B)(6) 2019. UVEITIS; PUPIL MEMBRANE WAS CLOSED, IRIS SYNECHIA WAS REPORTED. TREATMENT OF HORMONES; NON STEROIDAL ANTI-INFLAMMATORY DRUGS, MYDRIASIS TREATMENT, TREATMENT IMPROVED, REPEATED ATTACKS, AFTER CONSULTATION DECIDED TO TAKE OUT THE LENS. ON (B)(6) 2020 THE LENS WAS EXPLANTED AND THE PROBLEM WAS RESOLVED. H3- DEVICE EVALUATION: LENS RETURNED IN A MICRO-CENTRIFUGE VIAL WITH MOISTURE. VISUAL INSPECTION FOUND HAPTIC TORN. H6 CLINICAL CODE: 4581: PUPIL MEMBRANE CLOSED; IRIS SYNECHIA. HEALTH IMPACT: 4625: MYDRIASIS TREATMENT. HEALTH IMPACT : 4644: HORMONES; NON-STEROIDAL ANTI- INFLAMMATORY DRUGS. CLAIM# (B)(4).
PMA/510(K): THIS PRODUCT IS MANUFACTURED IN THE U.S. BUT NOT MARKETED IN THE U.S. INVESTIGATION TYPE 4110: LENS WORK ORDER SEARCH-NO SIMILAR COMPLAINT TYPE EVENTS REPORTED FOR UNITS WITHIN THE SAME LOT. CLAIM# (B)(4).
THE REPORTER INDICATED THE SURGEON IMPLANTED A 13.2MM VTICMO13.2 IMPLANTABLE COLLAMER LENS, -10.0/+2.0/089 (SPHERE/CYLINDER/AXIS) INTO THE PATIENT'S RIGHT EYE (OD) ON (B)(6) 2019. ON (B)(6) 2020 THE LENS WAS EXPLANTED, DIAGNOSTICS AND TREATMENT PERFORMED. THE CAUSE OF THE EVENT IS REPORTED AS UNKNOWN. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE NOT BEEN SUCCESSFUL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1389748 | IMPLANTABLE COLLAMER LENS (ICL) | PHAKIC TORIC INTRAOCULAR LENS | QCB | STAAR SURGICAL COMPANY | VTICMO13.2 | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 23 YR | Required Intervention |